JH
JHS Svendgaard Laboratories Limited
JHS.NS · NSE
₹9.08 +13.08% (+₹1.05)
1M -8.96%
Market Cap ₹708.0M
P/E Ratio -
Div. Yield -
ROE 1.09%
Bulios Fair Price
₹7.01
22.8% downside
Current Price
₹9.08
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JHS.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
79 /100
Cheap EV/EBITDA 14.01x
P/S 0.65x
P/B 0.41x
Growth
74 /100
Growing Rev. growth 6.54%
Book val. growth 0.16%
EPS growth N/A
Profitability
8 /100
Weak Gross margin 25.28%
Net margin 1.74%
Op. margin 4.06%
Quality
4 /100
Poor ROIC 1.52%
ROE 1.09%
ROA 0.88%
Debt
80 /100
Low Debt/Equity 0.09x
Current ratio 1.95x
Int. coverage -2.73x
Stability
30 /100
Unstable Beta 0.62x
Rev. volatility 24.45%
EPS volatility 253.82%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JHS.NS
Online
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Paramvir Singh Pabla
Employees
250
Headquarters
New Delhi